Active, Not Recruiting
Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)
NCT05771480
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
- Locations
-
- Research Site Mobile, Alabama, United States
- Research Site Orange, California, United States
- Research Site Washington D.C., District of Columbia, United States
- Research Site Portland, Oregon, United States